Status:
TERMINATED
Deep Brain Stimulation (DBS) Sedation
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Brain
Sedation
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
Deep brain stimulation (DBS) of different brain nuclei is a treatment for multiple brain disorders. The subthalamic nucleus (STN) and globus pallidus have been used to treat advanced Parkinson's disea...
Detailed Description
Deep brain stimulation (DBS) of different brain nuclei is evolving as an essential component of the treatment for multiple brain disorders. The subthalamic nucleus (STN) and globus pallidus have been ...
Eligibility Criteria
Inclusion
- All patients scheduled to undergo DBS electrode implantation surgery with MER that agree to participate in the experiment and sign an informed consent are candidates to participate in the study, unless one of the exclusion criteria is met
Exclusion
- Known or suspected obstructive sleep apnea.
- Suspected difficult intubation.
- Pregnancy (pregnancy test is standard care for women of childbearing age)
- Under 18 years of age or over 85 years of age
- Cognitive disability impairing understanding the experiment or signing the informed consent form.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03283150
Start Date
December 1 2017
End Date
January 20 2022
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53705